To assess the posterior segment findings in cases presenting with post covid mucormycosis. A cross-sectional observational study was conducted on patients presented with post-covid mucormycosis who were admitted in our hospital during the time period from 1/5/2021 to 1/9/2021. Our study included cases with and without orbital involvement. Anterior segment examination and fundus examination using indirect ophthalmoscopy was done. Findings were photo documented with fundus camera.: In a cohort of 248 patients, 183 (73.7%) were males and 65 (26.2%) were females. 210 (84.67%) were diabetics. The mean age was 50.00 +/-12.33 years. A total of 480 eyes were evaluated, out of which 151 (31.45%) had orbital involvement. Of these 151, 65 had normal fundus, 26 (17.21%) had diabetic retinopathy, 22 had CRAO, 12 had disc pallor, 10 had disc edema and 16 had miscellaneous changes. Out of 329 uninvolved eyes, 239 had normal fundus, 53 (16.10%) had diabetic retinopathy. There was no statistically significant difference between the prevalence of diabetic retinopathy in eyes with orbital involvement and without orbital involvement (p=.39). One-third of the patients with post-covid mucormycosis had retinal findings. These are related to direct disease manifestation as well as underlying co-morbidities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.